Certain populations should avoid GLP-1 probiotic supplements or use them only under close medical supervision due to elevated risk of adverse outcomes
Document any adverse effects, including timing, severity, and associated factors, to facilitate clinical assessment
37 Additionally, these agents reduce the levels of proinflammatory adipokines and the expression of inflammatory genes, which can improve overall metabolic health
Obesity and adipose tissue research Type 2 diabetes and insulin resistance Knee osteoarthritis Obstructive sleep apnea Non-alcoholic steatohepatitis (NASH) Key Findings from the Literature 01Phase 2: 24.2% mean weight loss at 48 weeks at highest dose 02Phase 3 TRIUMPH-4: 28.7% mean weight loss at 68 weeks 03Highest weight loss efficacy of any obesity pharmacotherapy in clinical trials to date 04Glucagon receptor agonism adds hepatic lipolysis absent from GLP-1-only agents 1 Independent third-party lab reports for this peptide
Healthmap Solutions acquires Carium to expand digital engagement
Lyophilized in Texas 99%+ Purity Guaranteed Our peptides are proudly lyophilized right here in the US, to exact specifications
